Atopic dermatitis
OX40 Targeted Therapies Clinical Trials, Therapeutic Approaches, and Market Opportunity Insight
The market for OX40/OX40L targeted therapies is rapidly evolving, with pharmaceutical investment and academia interest converging to bring forth a vibrant pipeline of contenders. Several candidates are currently in late-stage trials, and innovation is extending into combination strategies as well as diagnostic pairing. This report provides an overview of